Alena Skrahina

Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study

Susan E. Dorman, Samuel G. Schumacher, David Alland et al. · The Lancet Infectious Diseases · 2017 · 691 citations · Full text

Public Health, Infectious Diseases, Internal Medicine +17

The New Xpert MTB/RIF Ultra: Improving Detection of <i>Mycobacterium tuberculosis</i> and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing

Soumitesh Chakravorty, Ann Marie Simmons, Mazhgan Rowneki et al. · mBio · 2017 · 657 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +16

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

Borisov Se, Keertan Dheda, Martin Enwerem et al. · European Respiratory Journal · 2017 · 302 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis

Paolo Miotto, Claudio U. Köser, Philip W. Fowler et al. · The Lancet Microbe · 2022 · 300 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance

Abigail L. Manson, Keira A. Cohen, Thomas Abeel et al. · Nature Genetics · 2017 · 296 citations · Full text

Life Sciences, Genetics, Microbiology +16